The Hanover Insurance Group Inc
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at The Hanover Insurance Group Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 167.60 $ to 232.80 $ · Last price: 229.20 $ (As of: September 17, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/18/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Insurance - Property & Casualty
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| The Hanover Insurance Group Inc THG | 7.8 | 11.9 | 0.0 | 25.2 | 14.6 | 6.1 | 33.6 |
| Chubb Ltd CB | 132.6 | 12.7 | 0.0 | 31.1 | 20.6 | 6.5 | 27.1 |
| Progressive Corp PGR | 126.0 | 11.7 | 21.9 | 18.5 | 16.4 | 16.3 | -5.5 |
| The Travelers Companies Inc TRV | 79.1 | 11.7 | 0.0 | 34.7 | 18.7 | 5.2 | 40.1 |
| The Allstate Corporation ALL | 64.9 | 5.9 | 0.0 | 36.8 | 19.0 | 4.6 | 30.3 |
| W. R. Berkley Corp WRB | 26.1 | 15.4 | 0.0 | 43.8 | 17.1 | 7.8 | -1.5 |
| Cincinnati Financial Corporation CINF | 25.8 | 10.1 | 0.0 | 31.1 | 11.8 | 11.4 | 13.9 |
| Markel Corporation MKL | 21.9 | 13.2 | 0.0 | 51.9 | -9.7 | -1.0 | -7.4 |
| Loews Corp L | 21.8 | 14.2 | 0.0 | 36.3 | 11.8 | 5.4 | 12.2 |
| Median of companies shown | 26.1 | 11.9 | 0.0 | 34.7 | 16.4 | 6.1 | 13.9 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 3,966 | 66 | 155 | 3.59 | 743 | 2,858 | 14,220 |
| 2017 | 4,268 | 293 | 186 | 4.33 | 705 | 2,998 | 15,470 |
| 2018 | 4,466 | 283 | 391 | 9.09 | 551 | 2,955 | 12,400 |
| 2019 | 4,891 | 522 | 425 | 10.47 | 603 | 2,916 | 12,491 |
| 2020 | 4,819 | 445 | 359 | 9.41 | 708 | 3,202 | 13,444 |
| 2021 | 5,160 | 521 | 423 | 11.62 | 824 | 3,145 | 14,254 |
| 2022 | 5,433 | 144 | 116 | 3.21 | 722 | 2,334 | 13,995 |
| 2023 | 5,964 | 41 | 35 | 0.98 | 362 | 2,466 | 14,613 |
| 2024 | 6,217 | 538 | 426 | 11.70 | 806 | 2,842 | 15,275 |
| 2025 | 6,598 | 844 | 663 | 18.56 | 1,178 | 3,572 | 16,946 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 4.59 | 53.90 | 1,578 | 3.20 | 10.60 | 214 | 211 |
| 2025: Q1 | 3.52 | 10.70 | 1,596 | 3.50 | 8.00 | 39 | 37 |
| 2025: Q2 | 4.32 | 286.80 | 1,651 | 7.50 | 9.50 | 207 | 205 |
| 2025: Q3 | 4.91 | 75.50 | 1,658 | 6.20 | 10.80 | 554 | 551 |
| 2025: Q4 | 5.47 | 19.20 | 1,672 | 5.90 | 11.90 | 378 | 377 |
| 2026: Q1 | 5.15 | 46.10 | 1,701 | 6.60 | 11.00 | 119 | 115 |
| 2026: Q2 | 5.38 | 24.50 | 1,726 | 4.60 | 11.10 | 212 | 209 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 16 of our scanner strategies — each hit links to the scanner.
Growth
Quality & Balance Sheet
- Buffett Criteria (Buffettology)
- Buffett: Owner Earnings Yield
- Institutional Accumulation
- Levermann
- Pros 80%
Breakout & Setup
Momentum & Trend
Value & GARP
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Distribution of Recommendations
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 20.38 | 19.59 – 21.25 | 6,769 | 6.8% | 8 |
| 12/31/2027 | 19.53 | 18.80 – 20.24 | 7,058 | -4.2% | 8 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.
Today’s market value implies roughly -8.8% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).
| Free cash flow (last twelve months) | $1.25B |
|---|---|
| Market cap | $7.77B |
| Free cash flow in year ten | $498.3M |
| Terminal value as a share of market value | 33.8% |
For comparison: over the past five years free cash flow grew by 11.1% per year.
It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 6.7%
- More than 10% revenue growth is expected for the coming year 4.4%
- Share count grows by less than 3% a year -0.4%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 23.9%
- Gross margin at 40% or higher and without meaningful erosion 43.5%
- Goodwill from acquisitions does not grow faster than revenue 1.1%
- Net debt below twice EBITDA 1,778 m net cash
- Operating cash flow covers the profits of the last three years 1,222 m
- Return on capital at 15% or higher, or up versus two years ago 14.8%
- Insiders hold at least 10% or are net buyers 0.9%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
6/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 5.8%
- Exp. sales growth 3Y > 5% 3.4%
- EBIT growth 10Y > 5% 32.7%
- Exp. EBIT growth 3Y > 5% 2.6%
- Net debt < 4x EBIT -2.1x
- EBIT positive, 10Y straight 10
- Max. EBIT decline < 50% 92.1%
- Return on equity > 15% 24.6%
- ROCE > 15% 14.8%
- Expected return > 10% 18.0%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Kerrigan Dennis Francis | Executive Vice President | Sell | 1,704 | 222.97 | 379,941 |
| Aug 20, 2026 | Kerrigan Dennis Francis | Executive Vice President | Sell | 400 | 220.01 | 88,004 |
| Aug 20, 2026 | Kerrigan Dennis Francis | Executive Vice President | Other | 2,104 | 118.54 | 249,408 |
| Aug 19, 2026 | Kerrigan Dennis Francis | Executive Vice President | Sell | 224 | 222.77 | 49,900 |
| Aug 19, 2026 | Kerrigan Dennis Francis | Executive Vice President | Sell | 1,505 | 221.73 | 333,704 |
| Aug 19, 2026 | Kerrigan Dennis Francis | Executive Vice President | Sell | 4,822 | 220.41 | 1,062,817 |
| Aug 19, 2026 | Kerrigan Dennis Francis | Executive Vice President | Other | 6,551 | 118.54 | 776,556 |
| Aug 6, 2026 | Bunting Theodore H JR | Director | Sell | 600 | 230.20 | 138,120 |
| Aug 5, 2026 | Bunting Theodore H JR | Director | Sell | 600 | 228.03 | 136,818 |
| Aug 3, 2026 | Carlin Jane D | Director | Sell | 1,000 | 231.50 | 231,500 |
The company
About the Company
The Hanover Insurance Group, Inc. bietet über ihre Tochtergesellschaften verschiedene Sach- und Schadenversicherungsprodukte und -dienstleistungen für Privatpersonen und Unternehmen in den USA an.
- Employees
- 4,900
- Headquarters
- Worcester, MA
- Address
- 440 Lincoln Street, 01653 Worcester, United States
- Phone
- 508 855 1000
- Website
- hanover.com
- IPO Date
- 10/10/1995
- ISIN
- US4108671052
Management
| Name | Title | Birth Year |
|---|---|---|
| John Conner Roche | President, CEO & Director | 1964 |
| Jeffrey Mark Farber | Executive VP & CFO | 1965 |
| Richard William Lavey | Executive VP & COO | 1968 |
| Dennis Francis Kerrigan Jr. | Executive VP, Chief Legal Officer, Corporate Secretary & Interim Chief Human Resources Officer | 1965 |
| Bryan James Salvatore | Executive VP & President of Specialty | 1965 |
| Lindsay France Greenfield | Senior VP & Chief investment Officer | – |
| Patricia Ann Norton-Gatto | Senior VP, Corporate Controller & Principal Accounting Officer | 1968 |
| Oksana Lukasheva | Senior Vice President of Corporate Finance | – |
| Toni E. Mitchell | President of Technology & Life Sciences Business | – |
| Willard Ty-Lunn Lee | Executive VP and Chief Information & Innovation Officer | 1970 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
- 07/28/2026 HANOVER INSURANCE GROUP, INC. (THG): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
- 07/15/2026 HANOVER INSURANCE GROUP, INC. (THG): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits SEC ↗
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.